Emergent BioSolutions (EBS) Current Taxes (2012 - 2026)

Emergent BioSolutions' Current Taxes history runs 6 years deep, the most recent figure standing at $7.2 million for Q1 2026.

• On a quarterly basis, Current Taxes changed N/A year-over-year to $7.2 million in Q1 2026; TTM through Mar 2026 was $7.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $6.8 million, up 17.24% from the prior year.
• Current Taxes climbed to $7.2 million in Q1 2026 per EBS's latest filing, from $6.8 million in the prior quarter.
• Across five years, Current Taxes topped out at $7.2 million in Q1 2026 and bottomed at $5.8 million in Q4 2024.
• The 3-year median for Current Taxes is $6.8 million (2025), against an average of $6.6 million.
• Biggest YoY gain for Current Taxes was 17.24% in 2025; the steepest drop was 17.24% in 2025.
• Year by year, Current Taxes stood at $5.8 million in 2024, then increased by 17.24% to $6.8 million in 2025, then climbed by 5.88% to $7.2 million in 2026.
• Per Business Quant, the three latest EBS Current Taxes figures stand at $7.2 million (Q1 2026), $6.8 million (Q4 2025), and $5.8 million (Q4 2024).